ARLINGTON, Va., July 14, 2025 /PRNewswire/ — Kalorama Information, a leading authority in healthcare market intelligence, announces the release of its 30-Country IVD Market Atlas, 2025 (June Update)—an in-depth strategic resource offering the most comprehensive, country-specific analysis of the in vitro diagnostics (IVD) landscape across 30 key nations. With quarterly updates throughout the year, this data-rich report equips stakeholders with timely and actionable insights to navigate the fast-evolving global diagnostics market.
Timely Updates. Local Precision. Global Impact.
30-Country IVD Market Atlas, 2025 (June Update)
From the U.S., China, and Germany to Vietnam, Saudi Arabia, and South Africa, Kalorama’s 30-Country IVD Market Atlas delivers granular market sizing, forecasts through 2029, and segmentation across 20+ critical IVD categories, including:
- Molecular diagnostics (HIV, Hepatitis, Respiratory, HAI)
- POC testing (Pregnancy, Glucose, Infectious Disease)
- Immunoassays, Coagulation, Hematology, Histology
- Microbiology and Core Lab/Critical Care
Unlike fragmented or outdated country reports, this atlas provides a single, continuously updated source for understanding demand, regulation, and competition across the globe — ideal for strategic planning, product launches, market expansion, and M&A targeting.
Highlights in the 2025 June Update
- China emerges as the fastest-growing IVD market of the 30 countries tracked, with a projected CAGR nearing 9% through 2029—almost four times the growth of slower-expanding markets like Egypt, Russia, and Japan.
“China is one of the world’s largest and fastest-growing IVD markets, making it a key target for major vendors seeking to offset slower growth in developed economies,” said Daniel Granderson, Senior Editor at Kalorama Information. “In 2024, glucose monitoring alone accounted for over 20% of China’s IVD value—and that momentum is just beginning.”
- Countries such as Saudi Arabia, South Korea, Turkey, Vietnam, and the UAE are all forecast to exceed 5% CAGR, driven by expanding healthcare access, chronic disease burden, and tech adoption.
- Russia’s IVD market negatively impacted due to the withdrawal of foreign businesses surrounding the Ukraine war.
- The rise of AI, home testing, and personalized medicine continues to reshape diagnostics delivery across nearly all regions.
Who Should Read This Report?
The 30-Country IVD Market Atlas is designed for:
- Executive leadership and strategic planners at diagnostic and medtech companies
- Product and portfolio managers making localization or phase-out decisions
- Business development teams scouting M&A and partnership opportunities
- Investors and private equity analysts assessing country-level growth targets
- Regulatory professionals tracking compliance landscapes and approval trends
Get the Report Today
To access the full report or schedule a custom consultation, visit:
Purchase the 30-Country IVD Market Atlas, 2025
For custom research or enterprise access, contact:
Sheri Davie – Sales Director, Kalorama Information
[email protected]
For media inquiries, contact:
Richa Singh – Vice President, Strategic & Insights Sales
[email protected]
About Kalorama Information
A division of Science and Medicine Group, Kalorama Information has been a trusted publisher of healthcare market research for over 25 years. Its analysts specialize in in vitro diagnostics (IVD), biotechnology, medical devices, and pharmaceuticals. Kalorama is best known for its flagship title, The Worldwide Market for In Vitro Diagnostic Tests, and other authoritative benchmarks in the global medical technology space.
Kalorama works in close coordination with SMG brands including BioInformatics, SDi, and IMV, enabling deep insight across diagnostics, life sciences, and imaging markets.
Learn more at www.kaloramainformation.com
SOURCE Kalorama Information
